Zobrazeno 1 - 10
of 1 035
pro vyhledávání: '"Bettencourt BR"'
Autor:
Nguyen, Linh1 (AUTHOR), Nguyen, Tiep Tien1 (AUTHOR) tientiephup@skku.edu, Kim, Ju-Yeon1 (AUTHOR) jykimac@skku.edu, Jeong, Jee-Heon1 (AUTHOR) jeeheon@skku.edu
Publikováno v:
Journal of Nanobiotechnology. 11/30/2024, Vol. 22 Issue 1, p1-19. 19p.
Autor:
Schaeffer, Stephen W1 (AUTHOR) sws4@psu.edu, Richards, Stephen2 (AUTHOR), Fuller, Zachary L3 (AUTHOR)
Publikováno v:
G3: Genes | Genomes | Genetics. Oct2024, Vol. 14 Issue 10, p1-16. 16p.
Autor:
Dunaj SJ; Department of Biological Sciences, University of Massachusetts Lowell, Lowell, MA, USA., Bettencourt BR; Triplet Therapeutics, Cambridge, MA, USA., Garb JE; Department of Biological Sciences, University of Massachusetts Lowell, Lowell, MA, USA., Brucker RM; The Rowland Institute of Harvard University, Cambridge, MA, USA. brucker@rowland.harvard.edu.
Publikováno v:
BMC evolutionary biology [BMC Evol Biol] 2020 Aug 18; Vol. 20 (1), pp. 104. Date of Electronic Publication: 2020 Aug 18.
Autor:
Mostoufi, Sabrina L1 (AUTHOR) smostouf@uoregon.edu, Singh, Nadia D1 (AUTHOR)
Publikováno v:
G3: Genes | Genomes | Genetics. Sep2024, Vol. 14 Issue 9, p1-13. 13p.
Autor:
Petrosky, Sarah J1 (AUTHOR), Williams, Thomas M2 (AUTHOR), Rebeiz, Mark1 (AUTHOR) rebeiz@pitt.edu
Publikováno v:
G3: Genes | Genomes | Genetics. Sep2024, Vol. 14 Issue 9, p1-13. 13p.
Autor:
Kim, Bernard Y.1 (AUTHOR) bernardkim@stanford.edu, Gellert, Hannah R.1 (AUTHOR), Church, Samuel H.2 (AUTHOR), Suvorov, Anton3 (AUTHOR), Anderson, Sean S.4 (AUTHOR), Barmina, Olga5 (AUTHOR), Beskid, Sofia G.1 (AUTHOR), Comeault, Aaron A.6 (AUTHOR), Crown, K. Nicole7 (AUTHOR), Diamond, Sarah E.7 (AUTHOR), Dorus, Steve8 (AUTHOR), Fujichika, Takako9 (AUTHOR), Hemker, James A.10 (AUTHOR), Hrcek, Jan11 (AUTHOR), Kankare, Maaria12 (AUTHOR), Katoh, Toru13 (AUTHOR), Magnacca, Karl N.14 (AUTHOR), Martin, Ryan A.7 (AUTHOR), Matsunaga, Teruyuki15 (AUTHOR), Medeiros, Matthew J.16 (AUTHOR)
Publikováno v:
PLoS Biology. 7/18/2024, Vol. 22 Issue 7, p1-23. 23p.
Autor:
Soufizadeh, Parham1,2 (AUTHOR), Mansouri, Vahid1 (AUTHOR), Ahmadbeigi, Naser1 (AUTHOR) n-ahmadbeigi@tums.ac.ir
Publikováno v:
Laboratory Animal Research. 4/22/2024, Vol. 40 Issue 1, p1-18. 18p.
Autor:
Mowery, Monica A.1,2 (AUTHOR) mmowery@york.cuny.edu, Rosenwald, Laura C.3 (AUTHOR), Chapman, Eric3 (AUTHOR), Lubin, Yael1 (AUTHOR), Segoli, Michal1 (AUTHOR), Khoza, Thembile4 (AUTHOR), Lyle, Robin5 (AUTHOR), White, Jennifer A.3 (AUTHOR)
Publikováno v:
Scientific Reports. 4/12/2024, Vol. 14 Issue 1, p1-10. 10p.
Autor:
Liebow A; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and aliebow@alnylam.com., Li X; Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama., Racie T; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Hettinger J; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Bettencourt BR; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Najafian N; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Haslett P; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Fitzgerald K; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Holmes RP; Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama., Erbe D; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Querbes W; Alnylam Pharmaceuticals, Departments of Research and Development, Cambridge, Massachusetts; and., Knight J; Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama.
Publikováno v:
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2017 Feb; Vol. 28 (2), pp. 494-503. Date of Electronic Publication: 2016 Jul 18.
Autor:
Fitzgerald K; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., White S; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Borodovsky A; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Bettencourt BR; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Strahs A; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Clausen V; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Wijngaard P; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Horton JD; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Taubel J; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Brooks A; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Fernando C; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Kauffman RS; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Kallend D; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Vaishnaw A; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.)., Simon A; From Alnylam Pharmaceuticals, Cambridge, MA (K.F., S.W., A. Borodovsky, B.R.B., A. Strahs, V.C., R.S.K., A.V., A. Simon); the Medicines Company, Parsippany, NJ (P.W., D.K.); University of Texas Southwestern Medical Center, Dallas (J.D.H.); Richmond Pharmacology, St. George's University of London, London (J.T.); and Covance Clinical Research Unit, Leeds, United Kingdom (A. Brooks, C.F.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2017 Jan 05; Vol. 376 (1), pp. 41-51. Date of Electronic Publication: 2016 Nov 13.